15 October 2019
Visiongain has launched a new pharma report ‘’Medical Pendant Market Report 2020-2030’’ by Product (Fixed, Fixed Retractable, Single Arm Movable, Double & Multiarm Movable, Accessories), Application (Hospitals, Clinics), and Geography.
The global medical pendant market is anticipated to grow on account of increasing demand for sophisticated medical support technologies. The global Medical Pendant market is anticipated to grow at a lucrative CAGR of 7.3% and anticipated to surpass USD 200 Million by 2030.
A medical pendant is a wireless device intended to alert healthcare staff to an emergency or danger that needs urgent care. Medical pendant systems can be costly and involve the correct operation and installation by skilled engineers. Medical pendants can be bifurcated into active and passive alarm devices. Active systems involve the user's momentum to activate the alarm, while the passive device monitors the wearer and increases an alarm due to the absence of operation or failure.
The adoption of medical pendant technologies is fueled by the effective results obtained in endoscopy and surgery. Another factor driving the market is an increasing demand for sophisticated medical support technologies. Furthermore, the adoption of these systems is encouraged by innovation and technological advances that allow medical pendant systems to alert near and dear ones in case of emergency by pressing a button.
North America holds the majority of market share followed by Europe and will continue to dominate in the future as a result of several research projects in the region, coupled with funding for research institutes from the government. Also, the market will continue to be driven by the existence of the target population and increased R&D investment by important business organizations. Asia Pacific region is expected to experience the highest growth in terms of CAGR over the forecast period owing to the growing presence of cancer cases in markets such as India and China. Additionally, unmet needs of patients and untapped nations in this region have been attracting investments by global players and this is expected to boost medical pendant market growth over the forecast period. Also, the presence of favorable public policies, such as the Indian government's initiative on indigenous medical equipment manufacturing, is expected to give a boost to the growth of the Indian medical pendant market.
Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations and launching new products to strengthen their position in the global circulating tumor cells market. Companies are also increasing their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the market.
The comprehensive market report features companies such as BeaconMedæs, Brandon Medical Co Ltd, Elektra Hellas S.A., Hipac, Medilon, MEDIMAXKOREA, Megasan Medikal, Ondal Medical Systems GmbH, Skytron LLC, Starkstrom, Surgiris, Tedisel Medical, and Unicorn Medicals among other prominent players. Also the research study offers market estimation and forecast for the period ranging 2020–2030 for global markets such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific and MEA along with regional sub-markets as U.S., Canada, Brazil, Mexico, Germany, UK, France, Italy, Spain, Nordic, Benelux, Russia, Poland, India, Japan, China, Australia, ASEAN, GCC, South Africa and North Africa.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.
30 November 2020
The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.
26 November 2020
Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.
26 November 2020
Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.